BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruiz-Plazas X, Rodríguez-Gallego E, Alves M, Altuna-Coy A, Lozano-Bartolomé J, Portero-Otin M, García-Fontgivell JF, Martínez-González S, Segarra J, Chacón MR. Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness. J Transl Med 2019;17:307. [PMID: 31500625 DOI: 10.1186/s12967-019-2053-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Raimondo S, Gentile M, Esposito G, Gentile T, Ferrara I, Crescenzo C, Palmieri M, Cuomo F, De Filippo S, Lettieri G, Piscopo M, Montano L. Could Kallikrein-Related Serine Peptidase 3 Be an Early Biomarker of Environmental Exposure in Young Women? Int J Environ Res Public Health 2021;18:8833. [PMID: 34444582 DOI: 10.3390/ijerph18168833] [Reference Citation Analysis]
2 Altuna-Coy A, Ruiz-Plazas X, Alves-Santiago M, Segarra-Tomás J, Chacón MR. Serum Levels of the Cytokine TWEAK Are Associated with Metabolic Status in Patients with Prostate Cancer and Modulate Cancer Cell Lipid Metabolism In Vitro. Cancers (Basel) 2021;13:4688. [PMID: 34572917 DOI: 10.3390/cancers13184688] [Reference Citation Analysis]
3 Liang L, Cheng C, Hu G, Wang X, Liu J, Yan Z, Zeng W, Xia Y. TWEAK Promotes the Proliferation of Squamous Cell Carcinoma Cells Through Activating cIAP1 Signals. Front Oncol 2020;10:439. [PMID: 32351884 DOI: 10.3389/fonc.2020.00439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Frantzi M, Gomez-gomez E, Mischak H. Noninvasive biomarkers to guide intervention: toward personalized patient management in prostate cancer. Expert Review of Precision Medicine and Drug Development 2020;5:383-400. [DOI: 10.1080/23808993.2020.1804866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang Y, Yang X, Zhu XL, Wang ZZ, Bai H, Zhang JJ, Hao CY, Duan HB. A Novel Immune-Related Prognostic Biomarker and Target Associated With Malignant Progression of Glioma. Front Oncol 2021;11:643159. [PMID: 33937046 DOI: 10.3389/fonc.2021.643159] [Reference Citation Analysis]
6 Ruiz-Plazas X, Altuna-Coy A, Alves-Santiago M, Vila-Barja J, García-Fontgivell JF, Martínez-González S, Segarra-Tomás J, Chacón MR. Liquid Biopsy-Based Exo-oncomiRNAs Can Predict Prostate Cancer Aggressiveness. Cancers (Basel) 2021;13:E250. [PMID: 33440913 DOI: 10.3390/cancers13020250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]